Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic diagnosis of gastrointestinal cancer using 5-ALA
jRCTs051180148Active, not recruiting
- Sponsor
- SBI Pharmaceuticals
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 5-aminolevulinic acid in esophageal cancer, gastric cancer (GC), colorectal cancer (CRC) and 4 more, sponsored by SBI Pharmaceuticals. Primary endpoint: Diagnostic value of photodynamic diagnosis using 5-ALA. Started Jun 2012; status: active, not recruiting.
02
Drugs
5-aminolevulinic acid
03
Conditions
esophageal cancergastric cancer (GC)colorectal cancer (CRC)hepatocellular carcinoma (HCC)cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on jRCTs051180148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180148.